Author:
Parant M. A.,Parant F. J.,Le Contel C.,Lefrancier P.,Chedid L.
Reference23 articles.
1. M. Denis, D. Campbell, and E.O. Gregg, Interleukin-2 and granulocyte-macrophage colony-stimulating factor stimulate growth of a virulent strain of Escherichia coli, Infect. Immun. 59:1853 (1991).
2. M. Denis, Growth of Mycobacterium avium in human monocytes: identification of cytokines which reduce and enhance intracellular microbial growth. Eur. J. Immunol. 21:391 (1991).
3. C. Huber, and M. Herold, The importance of patient monitoring in clinical cytokine trials: use of serum markers to define biologically active doses. Cancer Surveys 8:809 (1989).
4. G. Antonelli, M. Currenti, O. Turriziani, and F. Dianzani. Neutralizing antibodies to interferon-alpha: Relative frequency in patients treated with different interferon preparations. J. Infect. Dis. 163:882 (1991).
5. F. Audibert, C. Leclerc, and L. Chedid. Muramyl peptides as immunopharmacological response modifiers, p. 307, in: “Biological Response Modifiers”, P.F. Torrence, ed., Academic Press, Orlando (1985).
Cited by
9 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献